IP Library Granted Patent US 9,797,908
Granted Patent B2
US 9,797,908 · App. 14/338,113 · Granted Oct 24, 2017

Unnatural reactive amino acid genetic code additions

Inventors: Alexander Deiters (La Jolla, CA); T. Ashton Cropp (Richmond, VA); Jason W. Chin (Cambridge, GB); J. Christopher Anderson (San Francisco, CA); Peter G. Schultz (La Jolla, CA)
Assignee: The Scripps Research Institute
G01N33/583C07C227/22C07C229/36C07C269/06C07C311/41C07K1/1072C07K1/13C07K14/001C07K16/18C09B11/08C09B57/00C12N9/93C12N15/67C12P17/04C12P21/02G01N33/532G01N33/582C12N2510/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,797,908
App. No.
14/338,113
Granted
Oct 24, 2017
Kind
B2
Abstract

This invention provides compositions and methods for producing translational components that expand the number of genetically encoded amino acids in eukaryotic cells. The components include orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases, orthogonal pairs of tRNAs/synthetases and unnatural amino acids. Proteins and methods of producing proteins with unnatural amino acids in eukaryotic cells are also provided.

Claims (10)

1. A composition comprising a protein, antibody, or antibody fragment, wherein the protein, antibody or antibody fragment comprises at least one unnatural amino acid comprising a first reactive group and at least one post-translational modification, wherein the at least one post-translational modification comprises attachment of a molecule comprising a second reactive group by a cycloaddition reaction to the at least one unnatural amino acid comprising the first reactive group;

wherein the unnatural amino acid comprising the first reactive group was incorporated into the protein, antibody or antibody fragment using an orthogonal translation system.

2. The composition of claim 1 , wherein the first reactive group is an alkynyl or azido moiety and the second reactive group is an azido or alkynyl moiety.

3. The composition of claim 2 , wherein the first reactive group is the alkynyl moiety and the second reactive group is the azido moiety.

4. The composition of claim 2 , wherein the first reactive group is the azido moiety and the second reactive group is the alkynyl moiety.

5. The composition of claim 1 , wherein the at least one post-translational modification is made in vivo in a eukaryotic cell.

6. The composition of claim 1 , further comprising a eukaryotic cell containing the protein, antibody, or antibody fragment.

7. The composition of claim 1 , wherein the unnatural amino acid is a p-azido-L-phenylalanine or a p-propargyloxyphenylalanine.

8. The composition of claim 1 , wherein the molecule is a dye, a polymer, a derivative of polyethylene glycol, a photocrosslinker, a cytotoxic compound, an affinity label, a derivative of biotin, a resin, a second protein or polypeptide, a metal chelator, a cofactor, a fatty acid, a carbohydrate, or a polynucleotide.

9. The composition of claim 1 , wherein the at least one unnatural amino acid was incorporated into the protein, antibody, or antibody fragment using an orthogonal synthetase comprising a polypeptide sequence selected from the group consisting of any one of SEQ ID NOs.: 48 to 63.

Continuity (7)
Division 13787400 · Mar 6, 2013
Continuation 13135129 · Jun 23, 2011
Continuation 10561121
Provisional Application 60493014 · Aug 5, 2003
Provisional Application 60496548 · Aug 19, 2003
Provisional Application 60479931 · Jun 18, 2003
Related Publication 20150018523A1 · Jan 15, 2015